vs
Axsome Therapeutics, Inc.（AXSM）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是Axsome Therapeutics, Inc.的1.1倍（$212.2M vs $196.0M），LiveRamp Holdings, Inc.净利率更高（18.8% vs -14.6%，领先33.4%），Axsome Therapeutics, Inc.同比增速更快（65.0% vs 8.6%），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（61.7% vs 11.1%）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
AXSM vs RAMP — 直观对比
营收规模更大
RAMP
是对方的1.1倍
$196.0M
营收增速更快
AXSM
高出56.4%
8.6%
净利率更高
RAMP
高出33.4%
-14.6%
两年增速更快
AXSM
近两年复合增速
11.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $196.0M | $212.2M |
| 净利润 | $-28.6M | $39.9M |
| 毛利率 | — | 71.9% |
| 营业利润率 | -13.8% | 18.6% |
| 净利率 | -14.6% | 18.8% |
| 营收同比 | 65.0% | 8.6% |
| 净利润同比 | 61.9% | 255.7% |
| 每股收益（稀释后） | $-0.55 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMRAMP
| Q4 25 | $196.0M | $212.2M | ||
| Q3 25 | $171.0M | $199.8M | ||
| Q2 25 | $150.0M | $194.8M | ||
| Q1 25 | $121.5M | $188.7M | ||
| Q4 24 | $118.8M | $195.4M | ||
| Q3 24 | $104.8M | $185.5M | ||
| Q2 24 | $87.2M | $176.0M | ||
| Q1 24 | $75.0M | $171.9M |
净利润AXSMRAMP
| Q4 25 | $-28.6M | $39.9M | ||
| Q3 25 | $-47.2M | $27.4M | ||
| Q2 25 | $-48.0M | $7.7M | ||
| Q1 25 | $-59.4M | $-6.3M | ||
| Q4 24 | $-74.9M | $11.2M | ||
| Q3 24 | $-64.6M | $1.7M | ||
| Q2 24 | $-79.3M | $-7.5M | ||
| Q1 24 | $-68.4M | $-5.4M |
毛利率AXSMRAMP
| Q4 25 | — | 71.9% | ||
| Q3 25 | — | 70.2% | ||
| Q2 25 | — | 70.1% | ||
| Q1 25 | — | 69.3% | ||
| Q4 24 | — | 71.9% | ||
| Q3 24 | — | 72.4% | ||
| Q2 24 | — | 70.6% | ||
| Q1 24 | — | 72.2% |
营业利润率AXSMRAMP
| Q4 25 | -13.8% | 18.6% | ||
| Q3 25 | -27.0% | 10.7% | ||
| Q2 25 | -24.5% | 3.7% | ||
| Q1 25 | -46.9% | -6.1% | ||
| Q4 24 | -61.1% | 7.5% | ||
| Q3 24 | -59.8% | 4.0% | ||
| Q2 24 | -89.5% | -3.0% | ||
| Q1 24 | -89.7% | -8.3% |
净利率AXSMRAMP
| Q4 25 | -14.6% | 18.8% | ||
| Q3 25 | -27.6% | 13.7% | ||
| Q2 25 | -32.0% | 4.0% | ||
| Q1 25 | -48.9% | -3.3% | ||
| Q4 24 | -63.1% | 5.7% | ||
| Q3 24 | -61.7% | 0.9% | ||
| Q2 24 | -91.0% | -4.3% | ||
| Q1 24 | -91.1% | -3.1% |
每股收益（稀释后）AXSMRAMP
| Q4 25 | $-0.55 | $0.62 | ||
| Q3 25 | $-0.94 | $0.42 | ||
| Q2 25 | $-0.97 | $0.12 | ||
| Q1 25 | $-1.22 | $-0.10 | ||
| Q4 24 | $-1.54 | $0.17 | ||
| Q3 24 | $-1.34 | $0.03 | ||
| Q2 24 | $-1.67 | $-0.11 | ||
| Q1 24 | $-1.44 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $322.9M | $403.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $88.3M | $962.3M |
| 总资产 | $689.8M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AXSMRAMP
| Q4 25 | $322.9M | $403.4M | ||
| Q3 25 | $325.3M | $376.9M | ||
| Q2 25 | $303.0M | $371.1M | ||
| Q1 25 | $300.9M | $420.8M | ||
| Q4 24 | $315.4M | $384.3M | ||
| Q3 24 | $327.3M | $348.4M | ||
| Q2 24 | $315.7M | $342.7M | ||
| Q1 24 | $331.4M | $368.9M |
股东权益AXSMRAMP
| Q4 25 | $88.3M | $962.3M | ||
| Q3 25 | $73.7M | $943.8M | ||
| Q2 25 | $73.1M | $947.8M | ||
| Q1 25 | $53.2M | $948.9M | ||
| Q4 24 | $57.0M | $957.7M | ||
| Q3 24 | $92.9M | $932.1M | ||
| Q2 24 | $102.9M | $951.9M | ||
| Q1 24 | $144.0M | $949.1M |
总资产AXSMRAMP
| Q4 25 | $689.8M | $1.3B | ||
| Q3 25 | $669.3M | $1.2B | ||
| Q2 25 | $639.8M | $1.2B | ||
| Q1 25 | $596.7M | $1.3B | ||
| Q4 24 | $568.5M | $1.3B | ||
| Q3 24 | $561.5M | $1.2B | ||
| Q2 24 | $548.2M | $1.2B | ||
| Q1 24 | $545.7M | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.7M | — |
| 自由现金流经营现金流 - 资本支出 | $-18.7M | — |
| 自由现金流率自由现金流/营收 | -9.6% | — |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-93.9M | — |
8季度趋势，按日历期对齐
经营现金流AXSMRAMP
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $1.0M | $57.4M | ||
| Q2 25 | $-32.4M | $-15.8M | ||
| Q1 25 | $-43.4M | — | ||
| Q4 24 | $-26.2M | $45.1M | ||
| Q3 24 | $-18.6M | $55.6M | ||
| Q2 24 | $-30.1M | $-9.3M | ||
| Q1 24 | $-53.5M | — |
自由现金流AXSMRAMP
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $988.0K | $56.8M | ||
| Q2 25 | $-32.4M | $-16.2M | ||
| Q1 25 | $-43.7M | — | ||
| Q4 24 | $-26.2M | $44.8M | ||
| Q3 24 | $-18.7M | $55.4M | ||
| Q2 24 | $-30.2M | $-9.6M | ||
| Q1 24 | $-53.6M | — |
自由现金流率AXSMRAMP
| Q4 25 | -9.6% | — | ||
| Q3 25 | 0.6% | 28.4% | ||
| Q2 25 | -21.6% | -8.3% | ||
| Q1 25 | -36.0% | — | ||
| Q4 24 | -22.1% | 22.9% | ||
| Q3 24 | -17.9% | 29.8% | ||
| Q2 24 | -34.6% | -5.4% | ||
| Q1 24 | -71.4% | — |
资本支出强度AXSMRAMP
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.3% | 0.2% | ||
| Q4 24 | 0.0% | 0.1% | ||
| Q3 24 | 0.1% | 0.1% | ||
| Q2 24 | 0.1% | 0.1% | ||
| Q1 24 | 0.1% | 1.0% |
现金转化率AXSMRAMP
| Q4 25 | — | — | ||
| Q3 25 | — | 2.09× | ||
| Q2 25 | — | -2.04× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
